You are here

  • Home
  • Archive
  • Volume 81, Issue 2
  • Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report

Article info

Article menu

Download PDFPDF

Correspondence
Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Free

Authors

  • Brigitte Bader-Meunier Pediatric Hematology-Immunology and Rheumatology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France INSERM UMR 1163, Laboratory of Immunogenetics of Paediatric Autoimmunity, Institut Imagine, Paris, France PubMed articlesGoogle scholar articles
  • Alice Hadchouel Pediatric Pneumology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France PubMed articlesGoogle scholar articles
  • Laureline Berteloot Pediatric Radiology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France PubMed articlesGoogle scholar articles
  • Laura Polivka Dermatology and Pediatric Dermatology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France PubMed articlesGoogle scholar articles
  • Vivien Béziat Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France Paris Descartes University, Imagine Institute, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Laurent Casanova Pediatric Hematology-Immunology and Rheumatology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France Paris Descartes University, Imagine Institute, Paris, France St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA Howard Hughes Medical Institute, New York, NY, USA PubMed articlesGoogle scholar articles
  • Romain Lévy Pediatric Hematology-Immunology and Rheumatology Unit, Hôpital Necker-Enfants Malades, AP-HP Centre, Paris, France Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France Paris Descartes University, Imagine Institute, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Brigitte Bader-Meunier, Service d'Immunologie- Hematologie et Rhumatologie Pediatrique, Hopital universitaire Necker-Enfants malades, Paris 75015, France; brigitte.bader-meunier{at}aphp.fr
View Full Text

Citation

Bader-Meunier B, Hadchouel A, Berteloot L, et al
Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Annals of the Rheumatic Diseases 2022;81:e20.

Publication history

  • Received January 12, 2020
  • Accepted January 15, 2020
  • First published February 13, 2020.
Online issue publication 
July 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.